Froimson Mark sold PCRX

March 17, 2026 · Form 4 insider transaction

Froimson Mark sold 500 shares of Pacira BioSciences, Inc. at $21.81 per share, a transaction worth $10.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.